Position in STTK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,839
New position
Shares Held
286,072
first reported quarter
Ownership
0.373%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,723 across 106 Biotechnology names. STTK ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,084 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,061 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,032 |
All Filings in STTK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,839 | 286,072 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||